Admin

Comparative genomics of mortal and immortal cnidarians unveils novel keys behind rejuvenation

While aging affects most living organisms, the hydrozoan Turritopsis dohrniiis the only species able to rejuvenate repeatedly after sexual reproduction, becoming biologically immortal. Setting the whole-genome of this metazoan is indispensable to study in depth mechanisms responsible for its immortal phenotype. Here, we report the genome assembly of T. dohrniiand its congeneric species Turritopsis rubra, …

Comparative genomics of mortal and immortal cnidarians unveils novel keys behind rejuvenation Read More »

The Emerging Field of Regenerative Medicine

“The Emerging Field of Regenerative Medicine” Featuring Dr. Ian White Regenerative Medicine is the fastest growing and most dynamic field to evolve out of the contemporary allopathic method of medicine. The current trajectory of medical evolution is unprecedented in our history and regenerative medicine is the driving influence guiding our advancements. But what is regenerative …

The Emerging Field of Regenerative Medicine Read More »

textbook

Stem Cell Production

“Stem Cell Production: Processes, Practices and Regulations” This book, published by Springer, examines the technologies and processes for the development and commercial production of stem cells according to cGMP guidelines. The American College of Regenerative Medicine’s Executive Board member, Asawari (Asa) Bapat contributed to this book through a chapter on, Global Regulations and Regenerative Medicine. …

Stem Cell Production Read More »

It’s the morning before your C-section, and someone wants you to donate your placenta

It’s the morning before your C-section, and someone wants you to donate your placenta January 2021 Frances Verter, PhD Placenta donation is a form of organ donation1. After birth (pun intended), the placenta and other birth tissues that are no longer needed to support the baby are expelled by the mother’s body and would typically …

It’s the morning before your C-section, and someone wants you to donate your placenta Read More »

Opinion: American Medical Society for Sports Medicine Position

Statement Principles for Responsible Use of Regenerative Medicine in Sports Medicine November 10, 2021 This recently published position statement by the AMSSM summarily articulates the opportunities, risks and considerations for inclusion of orthobiologics into a modern sports medicine practice. What leaps out at us, having been privy to the slow, at times chaotic, but seemingly inevitable …

Opinion: American Medical Society for Sports Medicine Position Read More »

lungs

New Cell Type Discovered Deep in Human Lungs – With Regenerative Properties

Findings shine light on underpinnings of COPD, pave new direction for future research on treatments. April 10, 2022 A new type of cell that resides deep within human lungs and may play a key role in human lung diseases has been discovered by researchers at the Perelman School of Medicine at the University of Pennsylvania. …

New Cell Type Discovered Deep in Human Lungs – With Regenerative Properties Read More »

pain in shoulder

Hospital for Special Study Looks at Healing and Outcomes for Rotator Cuff Surgery

Study Underway to See if Stem Cells Derived from Fat Tissue Can Enhance Healing and Outcomes in Rotator Cuff Surgery March 28, 2022 Researchers at Hospital for Special Surgery (HSS) have launched a study to see if injecting a type of stem cell derived from a patient’s own fat tissue could improve healing and shoulder …

Hospital for Special Study Looks at Healing and Outcomes for Rotator Cuff Surgery Read More »

Stem Cell Surgery Trials in Heart Failure and Diabetes

Stem Cell Surgery Trials in Heart Failure and Diabetes Jeffrey Weiss Functions as a resource for new treatments for patients with heart failure and diabetes mellitus Offers comprehensive information for physicians interested in stem cell technology Provides a template for others to develop stem cell treatments in their specialty Read More…

FDA grants fast track designation to donor-derived CAR-T for advanced kidney cancer

The FDA granted fast track designation to ALLO-316, an investigational chimeric antigen receptor T-cell therapy, for the treatment of adults with advanced or metastatic clear cell renal cell carcinoma. ALLO-316 (Allogene Therapeutics) is an allogeneic, gene-edited CAR T-cell therapy that targets the protein CD70 on the surface of cancer cells. The agent is derived from …

FDA grants fast track designation to donor-derived CAR-T for advanced kidney cancer Read More »